Hydrochloric Acid → HCID 58200262, compound
Reaction equation
C([Si](C)(C)[O:6][CH2:7][CH2:8][N:9]1[C:17]2[C:12](=[CH:13][C:14]([CH3:35])=[C:15]([NH:18][C:19]3[N:27]4[C:22]([CH2:23][O:24][CH2:25][C@H:26]4[C:28]4[CH:33]=[CH:32][C:31]([F:34])=[CH:30][CH:29]=4)=[N:21][N:20]=3)[CH:16]=2)[CH:11]=[N:10]1)(C)(C)C.Cl>CO>[F:34][C:31]1[CH:32]=[CH:33][C:28]([C@@H:26]2[CH2:25][O:24][CH2:23][C:22]3=[N:21][N:20]=[C:19]([NH:18][C:15]4[CH:16]=[C:17]5[C:12]([CH:11]=[N:10][N:9]5[CH2:8][CH2:7][OH:6])=[CH:13][C:14]=4[CH3:35])[N:27]23)=[CH:29][CH:30]=1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a stirring room temperature solution of {1-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-5-methyl-1H-indazol-6-yl}-[(R)-5-(4-fluoro-phenyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-yl]-amine (110 mg, 0.21 mmol) in MeOH (5 mL) was added 6N aqueous HCl (0.5 mL). The mixture was stirred at room temperature for 15 minutes and then concentrated under reduced pressure. The residue was recrystallized from MeOH/EtOAc/diethyl ether to give 70 mg of 2-{6-[(R)-5-(4-fluoro-phenyl)-5,6-dihydro-8H-[1,2,4]triazolo[3,4-c][1,4]oxazin-3-ylamino]-5-methyl-indazol-1-yl}-ethanol, MP=215-217° C., MS (M+H)=409.
Workup
- concentrationconcentrated under reduced pressure
- customThe residue was recrystallized from MeOH/EtOAc/diethyl ether
Sources & evidence
- ORD record
- ord-d17c8ecea0e849b785291dc83b945a3c
- Source dataset
- uspto-grants-2014_10
- Patent number
- US08871760B2
Reaction notes
Loading…